摘要
由于起病隐匿,肝癌发现时仅有20%~30%的患者有机会接受外科切除或肝移植治疗。目前,介入治疗已成为中期和部分晚期肝癌的首选方案,并且越来越多的学者认识到肝癌综合介入治疗的重要性和必要性。以经肝动脉化疗栓塞术（TACE）为主,联合多种方法（TACE联合局部治疗、TACE序贯手术治疗、TACE联合全身治疗）的综合介入治疗模式使得肝癌治疗手段更加丰富且疗效更佳。但联合治疗的适应证、时机选择以及治疗后复发、转移等问题仍需要未来进一步探索和研究。
In recent years, hepatocellular carcinoma （HCC） has become the second leading cause of cancer - related death worldwide. Due to the insidious onset of this disease, only 20% - 30% of the patients with HCC have the opportunity for surgical resection or liver transplan- tation. At present, interventional therapy has become the first choice for patients with intermediate - stage HCC and some patients with late - stage HCC, and more and more scholars have realized the importance and necessity of comprehensive interventional therapy for HCC. The comprehensive interventional therapy of transcatheter arterial chemoembolization （TACE） in combination with various methods （TACE com- bined with local treatment, TACE sequential surgery, or TACE combined with systemic treatment） provides many therapeutic approaches and achieves good therapeutic effects. However, the indications, timing, and recurrence and metastasis after treatment for such combination ther- apies await further investigation.
出处
《临床肝胆病杂志》
CAS
2016年第1期44-48,共5页
Journal of Clinical Hepatology
关键词
肝肿瘤
放射学
介入性
化学栓塞
治疗性
综合疗法
liver neoplasms
radiology, interrentional
ehemoembolization, therapeutic
combined modality therapy
